However, the confirmed diagnosis of NAFLD is the liver biopsy, and the blood collection of ALT level is invasive and could be impractical in large-scale, population-based epidemiological studies. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.